Lotz, Gregor P.
Benstein, Karin
Bloem, Karien
Buddiger, Harm
Calonder, Claudio
Elm, Stefanie
Fernandez, Elena
Goodman, Joanne
Gorovits, Boris
Grudzinska-Goebel, Joanna
Janssen, Melody
Jawa, Vibha
Kramer, Daniel
Luo, Linlin
Malisauskas, Mantas
Michaut, Lydia
Schäfer, Martin
Spindeldreher, Sebastian
Ullmann, Martin
Nana Weldingh, Karin
Kromminga, Arno
Snoeck, Veerle
Article History
Received: 18 March 2022
Accepted: 14 April 2022
First Online: 12 May 2022
Declarations
:
: The views and conclusions presented in this manuscript are those of the Immunogenicity Strategy Working Group of the European Immunogenicity Platform (EIP) and do not necessarily reflect the representative affiliation or individual company’s position of the authors on the subject.
: No external funding was received for this work.
: • Conception of manuscript: EIP working group (all authors)• Manuscript design and writing: GPL, BG, MU, AK, VS• Manuscript reviewing and editing: all authors• All authors read and agreed to the final version of the manuscript.
: G. P. L. is an employee of Roche Diagnostics GmbH, there is no conflict of interestK.B. is an employee of Sanofi-Aventis Deutschland GmbH, there is no conflict of interestK. Bloem is an employee of Sanquin Diagnostic Services, there is no conflict of interestH.B. is an employee of Genmab, there is no conflict of interestC.C. is an employee of Novartis Pharma AG, there is no conflict of interestS.E. is an employee of Amgen Research (Munich) GmbH, there is no conflict of interestE.F. was an employee of Roche, there is no conflict of interestJ. G. is an employee of AstraZeneca, there is no conflict of interestB.G. is an employee of Sana Biotechnology, there is no conflict of interestJ.G-G. is an employee of Bayer AG, there is no conflict of interestM.J. is a consultant and owner of SciPot Consultancy and has no conflict of interest.VJ is an employee of Bristol Myers Squibb, there is no conflict of interestD.K. is an employee of Sanofi Aventis Deutschland GmbH, there is no conflict of interestLinlin is an employee of Merck & Co. Inc, there is no conflict of interestM.M. was an employee of Merck Healthcare KGaA, there is no conflict of interestL.M. was a consultant for Integrated Biologix GmbH and has no conflict of interest.M.S. is an employee of Roche Diagnostics GmbH, there is no conflict of interestS.S. is a consultant and co-owner of Integrated Biologix GmbH and has no conflict of interestM.U. is an employee of Fresenius-Kabi, there is no conflict of interest.K. N. W. is an employee of Novo Nordisk A/S, there is no conflict of interestA.K. is an independent consultant and faculty member of the University of Kiel, Germany. No conflict of interest.V.S. is an employee of UCB Biopharma SRL, there is no conflict of interest